• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New Technology Is Biggest Hurdle for Sites Running Decentralized Trials

New Technology Is Biggest Hurdle for Sites Running Decentralized Trials

November 8, 2021

Implementing new technology, such as eSource and eConsent systems and sponsor portals, is the biggest challenge sites face in organizing and running decentralized and hybrid trials, according to a new survey of sponsors and CROs.

Seventy percent of Veeva Systems’ 226 survey respondents cited technology adoption, followed by 59 percent naming overcoming internal resistance to change and obtaining stakeholder buy-in as a hurdle.

Data protection and patient privacy were also big concerns, with 51 percent naming them as a hurdle, followed closely by potential burdens for technology-averse patients (50 percent). Less than half of respondents named compliance (45 percent) and data collection/reporting (44 percent) as stumbling blocks.

Respondents were well aware of the need to reduce site burden when implementing decentralized/hybrid approaches; two-thirds of CROs and a little more than half of sponsors said they were prioritizing site technology and focusing on reducing the number of different technologies sites need to onboard. One respondent said they planned to put resources into physician and site coordinator training earlier on, while another cited the need “to provide a helping hand, a white glove approach to help [sites] with efficient execution.”

Access the full survey here: https://bit.ly/2ZEiFdf.

 

To view more CenterWatch Weekly stories, click here.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing